S B Kaye - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

S B Kaye

Showing results (351-360 of 411) with videos related to

Pageof 42

Sort By:

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1992

The Second Medical Research Council study of prognostic factors in nonseminomatous germ cell tumors. Medical Research Council Testicular Tumour Working PartyG M Mead, S P Stenning, M C Parkinson, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997

Importance of bleomycin in combination chemotherapy for good-prognosis testicular nonseminoma: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative GroupR de Wit, G Stoter, S B Kaye, et al.

European Journal of Cancer & Clinical Oncology|November 1, 1983

On the receiving end--II. Linear analogue self-assessment (LASA) in evaluation of aspects of the quality of life of cancer patients receiving therapyA Coates, C F Dillenbeck, D R McNeil, et al.

British Journal of Cancer|February 13, 2001

Docetaxel-carboplatin as first line chemotherapy for epithelial ovarian cancerP A Vasey, R Atkinson, R Coleman, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2002

Phase I trial of intraperitoneal injection of the E1B-55-kd-gene-deleted adenovirus ONYX-015 (dl1520) given on days 1 through 5 every 3 weeks in patients with recurrent/refractory epithelial ovarian cancerP A Vasey, L N Shulman, S Campos, et al.

American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 15, 2016

The Influence of Donor and Recipient Gender Incompatibility on Corneal Transplant Rejection and FailureC L Hopkinson, V Romano, R A Kaye, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 4, 1999

Phase I/pharmacokinetic study of the topoisomerase I inhibitor GG211 administered as a 21-day continuous infusionJ P Stevenson, D DeMaria, J Sludden, et al.

Clinical Oncology (Royal College of Radiologists (Great Britain))|December 12, 2017

Clinical Outcome of Patients with Advanced Biliary Tract Cancer in a Dedicated Phase I UnitR Sundar, A Custodio, A Petruckevich, et al.

The British Journal of Surgery|September 1, 1984

Advanced gastric cancer: experience in Scotland using 5-fluorouracil, adriamycin and mitomycin-CD Cunningham, M Soukop, C S McArdle, et al.

European Journal of Cancer (Oxford, England : 1990)|January 1, 1991

EORTC New Drug Development Office coordinating and monitoring programme for phase I and II trials with new anticancer agentsG Schwartsmann, J Wanders, I J Koier, et al.

Pageof 42

Search research articles

Showing results (351-360 of 411) with videos related to

Sort By:

Pageof 42

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1992

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997

European Journal of Cancer & Clinical Oncology|November 1, 1983

On the receiving end--II. Linear analogue self-assessment (LASA) in evaluation of aspects of the quality of life of cancer patients receiving therapyA Coates, C F Dillenbeck, D R McNeil, et al.

British Journal of Cancer|February 13, 2001

Docetaxel-carboplatin as first line chemotherapy for epithelial ovarian cancerP A Vasey, R Atkinson, R Coleman, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2002

American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 15, 2016

The Influence of Donor and Recipient Gender Incompatibility on Corneal Transplant Rejection and FailureC L Hopkinson, V Romano, R A Kaye, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 4, 1999

Phase I/pharmacokinetic study of the topoisomerase I inhibitor GG211 administered as a 21-day continuous infusionJ P Stevenson, D DeMaria, J Sludden, et al.

Clinical Oncology (Royal College of Radiologists (Great Britain))|December 12, 2017

Clinical Outcome of Patients with Advanced Biliary Tract Cancer in a Dedicated Phase I UnitR Sundar, A Custodio, A Petruckevich, et al.

The British Journal of Surgery|September 1, 1984

Advanced gastric cancer: experience in Scotland using 5-fluorouracil, adriamycin and mitomycin-CD Cunningham, M Soukop, C S McArdle, et al.

European Journal of Cancer (Oxford, England : 1990)|January 1, 1991

EORTC New Drug Development Office coordinating and monitoring programme for phase I and II trials with new anticancer agentsG Schwartsmann, J Wanders, I J Koier, et al.

Pageof 42